Turkish Competition Authority releases pharmaceutical sector report

The Turkish Competition Authority has released an investigation report regarding the pharmaceutical sector, aimed at identifying structural competition issues and proposing targeted solutions to enhance consumer welfare.

The investigation, which began in December 2021, analyzes the industry's dynamics across production, market entry, and distribution stages. Key areas of focus include the balance between intellectual property protections, such as patents, and the necessity of maintaining free market entry conditions. The report also examines how regulatory frameworks and recent enterprise behaviors impact accessibility and safety.

In the distribution phase, the authority evaluated the effects of transformations in public drug procurement methods and the impact of vertical relationships on healthy competition. The report highlights potential risks, including atypical competition violations and exclusivity practices, while offering actionable recommendations to improve the sector's competitive structure without requiring radical changes to existing administrative or legal frameworks.